ArticleBMJ (Clinical research ed.)2024

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.

No numbers read from the abstract.

Not cited yet